Global Information
회사소개 | 문의

세계의 동물 및 가축용 백신 시장 예측(-2022년) : 돼지파보바이러스, 돼지유행성 폐렴, 조류인플루엔자, 광견병, 클로스트리듐 감염증

Veterinary/Animal Vaccines Market by Type (Porcine, Poultry, Companion Animal, Aquaculture), Disease (Porcine Parvovirus, Swine Pneumonia, Avian Influenza, Rabies, Clostridial Diseases), Technology - Global Forecast to 2022

리서치사 MarketsandMarkets
발행일 2017년 11월 상품 코드 281737
페이지 정보 영문 158 Pages
가격
US $ 5,650 ₩ 6,377,700 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,650 ₩ 7,506,500 PDF by E-mail (5-user license) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,150 ₩ 9,199,700 PDF by E-mail (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없지만, 동일 국가의 동일 사업장에 한정되며 해외지점 등은 포함되지 않습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,000 ₩ 11,288,000 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 동물 및 가축용 백신 시장 예측(-2022년) : 돼지파보바이러스, 돼지유행성 폐렴, 조류인플루엔자, 광견병, 클로스트리듐 감염증 Veterinary/Animal Vaccines Market by Type (Porcine, Poultry, Companion Animal, Aquaculture), Disease (Porcine Parvovirus, Swine Pneumonia, Avian Influenza, Rabies, Clostridial Diseases), Technology - Global Forecast to 2022
발행일 : 2017년 11월 페이지 정보 : 영문 158 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

한글목차

세계의 동물 및 가축용 백신 시장은 2017-2022년간 5.9%의 연평균 성장률(CAGR)로 성장을 지속하여 2017년에는 65억 달러, 2022년에는 86억 6,000만 달러에 이를 것으로 예측됩니다. 가축수 증가와 반복되는 전염병 발생, 반려동물의 인기, 인간과 가축 공통의 전염병 발생률 상승, 관련 기관의 사업 정비, 새로운 유형의 백신 도입 등의 요인이 시장 성장을 촉진하고 있습니다.

세계의 동물 및 가축용 백신(Veterinary/Animal Vaccines) 시장에 대해 조사했으며, 시장 및 제품 개요, 시장 성장에 대한 각종 영향요인과 시장 기회, 종류·질병·기술·지역별 동향, 시장 규모와 예측, 경쟁 구도, 주요 기업 개요 등의 정보를 전해드립니다.

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 주요 조사 결과

  • 동물 및 가축용 백신 시장 개요
  • 아시아태평양의 동물 및 가축용 백신 시장 : 기술별, 지역별
  • 가금용 백신 시장 : 질병별
  • 동물 및 가축용 백신 시장 : 지역별

제5장 시장 개요

  • 서론
  • 시장 역학
    • 성장 촉진요인
      • 가축수 증가와 반복되는 전염병의 발생
      • 반려동물의 인기 증가
      • 인간과 가축 공통의 전염병 발생률 상승
      • 새로운 유형의 백신 도입
    • 성장 저해요인
      • 백신 보관 비용
    • 기회
      • 기술 발전
      • 신흥 경제국에서 높아지는 동물 및 가축 건강에 대한 의식
    • 해결해야 할 과제
      • 불충분한 전염병 감시 및 보고 시스템

제6장 세계의 동물 및 가축용 백신 시장 : 종류별

  • 서론
  • 돼지용 백신
  • 가금용 백신
  • 가축용 백신
    • 소용 백신
    • 소형 반추동물용 백신
  • 반려동물용 백신
    • 개용 백신
    • 고양이용 백신
  • 수산양식 동물용 백신
  • 기타

제7장 세계의 동물 및 가축용 백신 시장 : 질병별

  • 서론
  • 돼지
  • 가금
  • 가축
    • 소형 반추동물
  • 반려동물
    • 고양이
  • 수산양식 동물
  • 기타

제8장 세계의 동물 및 가축용 백신 시장 : 기술별

  • 서론
  • 약독화 생백신(LAV)
  • 비활성화 백신
  • 톡소이드 백신
  • 재조합 백신
  • 기타

제9장 세계의 동물 및 가축용 백신 시장 : 지역별

  • 서론
  • 유럽
  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 태국
    • 인도
    • 기타
  • 기타 지역

제10장 경쟁 구도

  • 시장 순위 분석

제11장 기업 개요

  • 서론
  • ZOETIS
  • MERCK ANIMAL HEALTH
  • BOEHRINGER INGELHEIM
  • ELANCO
  • CEVA
  • VIRBAC
  • VETOQUINOL
  • PHIBRO ANIMAL HEALTH
  • HESTER
  • HIPRA
  • IDT BIOLOGIKA
  • BIOGENESIS BAGO
  • TIANJIN RINGPU
  • CHINA ANIMAL HUSBANDRY
  • JINYU BIO-TECHNOLOGY

제12장 부록

KSM 17.11.13

영문목차

"Veterinary Vaccines market is projected to register a CAGR of 5.9%"

The veterinary vaccines market is expected to reach USD 8.66 billion by 2022 from USD 6.50 billion in 2017, growing at a CAGR of 5.9% during the forecast period. Market growth can be attributed to factors such as growth in livestock population and repeated breakouts of livestock diseases; increasing adoption of companion animals; rising incidence of zoonotic diseases; initiatives by various government agencies, animal associations, and leading players; and the introduction of new types of vaccines in the market. On the other hand, the high storage cost for vaccines is expected to restrain the market to a certain extent.

"The companion animal vaccines segment is expected to grow at the highest rate during the forecast period"

On the basis of type, the veterinary vaccines market is segmented into porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquaculture vaccines, and other vaccines. The companion animal vaccines segment is divided into canine vaccines and feline vaccines and in terms of value, the companion animal vaccines segment is expected grow at the highest CAGR during the forecast period. Increasing awareness about companion animal vaccination, rising prevalence of zoonotic diseases in humans, and the growing number of pets and increasing pet ownership are fueling the demand for these vaccines.

"The live attenuated vaccines segment is expected to account for the largest share of the market in 2017"

By technology, the market is classified into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines and other vaccines. In terms of value, the live attenuated vaccines segment is expected to account for the largest share of the market in 2017. The ease of administration and long-term immunity offered by the live attenuated vaccine technologies are driving the demand for this segment in the veterinary vaccines industry.

"Asia Pacific to provide significant growth opportunities during the forecast period"

Geographically, Europe is the largest market for veterinary vaccines market, followed by North America but the APAC region is expected to witness the highest growth in the forecast period. This growth is primarily attributed to rising pet adoption, expansion of key vaccine players in the region, and the wide range of product launches and investments in veterinary vaccines manufacturing facilities in the region, especially in India, China, and Thailand.

Break-up Profile of Primaries:

  • By Company Type- Tier 1-40%, Tier 2-35% and Tier 3-25%
  • By Designation-C-level-33%, D-level-41% and Others-26%
  • By Region-North America-35%, Europe-30%, Asia-21%, and RoW-14%

The key players in the veterinary vaccines market are Zoetis (US), Merck Animal Health (US), Elanco (US), Boehringer Ingelheim (Germany), Ceva (France), Phibro Animal Health (US), and Virbac (France).

Research Coverage:

The veterinary vaccines market in this report is segmented by type, disease, technology, and region. The study tracks and analyzes competitive developments such as product launches; expansions; agreements, partnerships, and collaborations; and acquisitions. It also profiles the key players and their core competencies within the veterinary vaccines market.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on portfolios offered by the top players in the global veterinary vaccines market. The report analyzes the veterinary vaccines market by type, disease, technology, and region.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the veterinary vaccines market
  • Market Development: Comprehensive information about lucrative emerging markets - the report analyzes the markets for veterinary vaccines across regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the global veterinary vaccines market
  • Competitive Assessment: In-depth assessment of, strategies, products, and manufacturing capabilities of the key players in the global veterinary vaccines market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Breakdown of primary interviews
      • 2.1.2.3. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.3.1. RESEARCH ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL VETERINARY VACCINES MARKET OVERVIEW
  • 4.2. APAC VETERINARY VACCINES MARKET, BY TECHNOLOGY AND REGION
  • 4.3. POULTRY VETERINARY VACCINES MARKET, BY DISEASE
  • 4.4. VETERINARY VACCINES MARKET, BY GEOGRAPHY

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Growth in livestock population and repeated outbreaks of livestock diseases
      • 5.2.1.2. Increasing adoption of companion animals
      • 5.2.1.3. Rising incidence of zoonotic diseases
      • 5.2.1.4. Initiatives by various government agencies, animal associations, and leading players
      • 5.2.1.5. Introduction of new types of vaccines
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High storage costs for vaccines
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Technological advancements
      • 5.2.3.2. Growing awareness of animal health in emerging economies
    • 5.2.4. CHALLENGE
      • 5.2.4.1. Inadequate surveillance and reporting systems

6. VETERINARY VACCINES MARKET, BY TYPE

  • 6.1. INTRODUCTION
  • 6.2. PORCINE VACCINES
  • 6.3. POULTRY VACCINES
  • 6.4. LIVESTOCK VACCINES
    • 6.4.1. BOVINE VACCINES
    • 6.4.2. SMALL RUMINANT VACCINES
  • 6.5. COMPANION ANIMAL VACCINES
    • 6.5.1. CANINE VACCINES
    • 6.5.2. FELINE VACCINES
  • 6.6. AQUACULTURE VACCINES
  • 6.7. OTHER ANIMAL VACCINES

7. VETERINARY VACCINES MARKET, BY DISEASE

  • 7.1. INTRODUCTION
  • 7.2. PORCINE
  • 7.3. POULTRY
  • 7.4. LIVESTOCK
    • 7.4.1. BOVINE
    • 7.4.2. SMALL RUMINANTS
  • 7.5. COMPANION ANIMALS
    • 7.5.1. CANINE
    • 7.5.2. FELINE
  • 7.6. AQUACULTURE

8. VETERINARY VACCINES MARKET, BY TECHNOLOGY

  • 8.1. INTRODUCTION
  • 8.2. LIVE ATTENUATED VACCINES
  • 8.3. INACTIVATED VACCINES
  • 8.4. TOXOID VACCINES
  • 8.5. RECOMBINANT VACCINES
  • 8.6. OTHER VACCINES

9. VETERINARY VACCINES MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. EUROPE
  • 9.3. NORTH AMERICA
    • 9.3.1. US
    • 9.3.2. CANADA
  • 9.4. ASIA PACIFIC (APAC)
    • 9.4.1. CHINA
    • 9.4.2. THAILAND
    • 9.4.3. INDIA
    • 9.4.4. REST OF APAC
  • 9.5. REST OF THE WORLD

10. COMPETITIVE LANDSCAPE

  • 10.1. MARKET RANKING ANALYSIS

11. COMPANY PROFILES (BUSINESS OVERVIEW, PRODUCTS OFFERED, STRENGTH OF PRODUCT PORTFOLIO, BUSINESS STRATEGY EXCELLENCE, RECENT DEVELOPMENTS.)*

  • 11.1. ZOETIS
  • 11.2. MERCK ANIMAL HEALTH
  • 11.3. BOEHRINGER INGELHEIM
  • 11.4. ELANCO
  • 11.5. CEVA
  • 11.6. VIRBAC
  • 11.7. VETOQUINOL
  • 11.8. PHIBRO ANIMAL HEALTH
  • 11.9. HESTER
  • 11.10. HIPRA
  • 11.11. IDT BIOLOGIKA
  • 11.12. BIOGENESIS BAGO
  • 11.13. TIANJIN RINGPU
  • 11.14. CHINA ANIMAL HUSBANDRY
  • 11.15. JINYU BIO-TECHNOLOGY

*Details on Business Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key relationships might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS
  • 12.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL LIVESTOCK ANIMAL POPULATION, 2000 AND 2013
  • TABLE 2: ANIMAL DISEASE OUTBREAKS REPORTED IN RECENT YEARS
  • TABLE 3: PERCENTAGE OF PET OWNERSHIP, BY COUNTRY, 2016
  • TABLE 4: SMALL COMPANION ANIMAL POPULATION, BY COUNTRY, 2014 VS. 2016 (MILLION)
  • TABLE 5: VETERINARY VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 6: PORCINE VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: NORTH AMERICA: PORCINE VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 8: ASIA PACIFIC: PORCINE VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 9: POULTRY VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: NORTH AMERICA: POULTRY VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 11: ASIA PACIFIC: POULTRY VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 12: LIVESTOCK VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: NORTH AMERICA: LIVESTOCK VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 14: ASIA PACIFIC: LIVESTOCK VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 15: LIVESTOCK VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 16: BOVINE VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: NORTH AMERICA: BOVINE VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 18: ASIA PACIFIC: BOVINE VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 19: SMALL RUMINANT VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: NORTH AMERICA: SMALL RUMINANT VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 21: ASIA PACIFIC: SMALL RUMINANT VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 22: COMPANION ANIMAL VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 24: ASIA PACIFIC: COMPANION ANIMAL VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 25: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 26: CANINE VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 27: NORTH AMERICA: CANINE VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 28: ASIA PACIFIC: CANINE VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 29: FELINE VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 30: NORTH AMERICA: FELINE VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 31: ASIA PACIFIC: FELINE VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 32: AQUACULTURE VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 33: NORTH AMERICA: AQUACULTURE VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 34: OTHER ANIMAL VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 35: NORTH AMERICA: OTHER ANIMAL VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 36: PORCINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 37: PORCINE CIRCOVIRUS II VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 38: NORTH AMERICA: PORCINE CIRCOVIRUS II VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 39: ASIA PACIFIC: PORCINE CIRCOVIRUS II VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 40: PORCINE REPRODUCTIVE RESPIRATORY SYNDROME VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 41: NORTH AMERICA: PORCINE REPRODUCTIVE RESPIRATORY SYNDROME VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 42: ASIA PACIFIC: PORCINE REPRODUCTIVE RESPIRATORY SYNDROME VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 43: PORCINE PARVOVIRUS VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 44: NORTH AMERICA: PORCINE PARVOVIRUS VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 45: ASIA PACIFIC: PORCINE PARVOVIRUS VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 46: POULTRY VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 47: INFECTIOUS BRONCHITIS VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 48: NORTH AMERICA: INFECTIOUS BRONCHITIS VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 49: ASIA PACIFIC: INFECTIOUS BRONCHITIS VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 50: AVIAN INFLUENZA VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 51: NORTH AMERICA: AVIAN INFLUENZA VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 52: ASIA PACIFIC: AVIAN INFLUENZA VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 53: NEWCASTLE DISEASE VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 54: NORTH AMERICA: NEWCASTLE DISEASE VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 55: ASIA PACIFIC: NEWCASTLE DISEASE VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 56: BOVINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 57: FOOT-AND-MOUTH DISEASE VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 58: BOVINE VIRAL DIARRHEA VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 59: BOVINE CLOSTRIDIAL DISEASE VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 60: BRUCELLOSIS VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 61: SMALL RUMINANT VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 62: CANINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 63: FELINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 64: AQUACULTURE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 65: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 66: LIVE ATTENUATED VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 67: NORTH AMERICA: LIVE ATTENUATED VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 68: ASIA PACIFIC: LIVE ATTENUATED VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 69: INACTIVATED VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 70: NORTH AMERICA: INACTIVATED VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 71: ASIA PACIFIC: INACTIVATED VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 72: TOXOID VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 73: NORTH AMERICA: TOXOID VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 74: ASIA PACIFIC: TOXOID VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 75: RECOMBINANT VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 76: NORTH AMERICA: RECOMBINANT VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 77: ASIA PACIFIC: RECOMBINANT VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 78: OTHER VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 79: NORTH AMERICA: OTHER VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 80: ASIA PACIFIC: OTHER VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 81: VETERINARY VACCINES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 82: EUROPE: VETERINARY VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 83: EUROPE: LIVESTOCK VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 84: EUROPE: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 85: EUROPE: PORCINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 86: EUROPE: POULTRY VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 87: EUROPE: BOVINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 88: EUROPE: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 89: NORTH AMERICA: VETERINARY VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 90: NORTH AMERICA: LIVESTOCK VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 91: NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 92: NORTH AMERICA: PORCINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 93: NORTH AMERICA: POULTRY VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 94: NORTH AMERICA: BOVINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 95: NORTH AMERICA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 96: NORTH AMERICA: VETERINARY VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 97: US: VETERINARY VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 98: US: LIVESTOCK VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 99: US: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 100: US: PORCINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 101: US: POULTRY VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 102: US: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 103: CANADA: VETERINARY VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 104: CANADA: LIVESTOCK VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 105: CANADA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 106: CANADA: PORCINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 107: CANADA: POULTRY VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 108: CANADA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 109: ASIA PACIFIC: VETERINARY VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 110: ASIA PACIFIC: LIVESTOCK VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 111: ASIA PACIFIC: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 112: ASIA PACIFIC: PORCINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 113: ASIA PACIFIC: POULTRY VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 114: ASIA PACIFIC: BOVINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 115: ASIA PACIFIC: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 116: ASIA PACIFIC: VETERINARY VACCINES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 117: CHINA: VETERINARY VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 118: CHINA: LIVESTOCK VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 119: CHINA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 120: CHINA: PORCINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 121: CHINA: POULTRY VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 122: CHINA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 123: THAILAND: VETERINARY VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 124: THAILAND: LIVESTOCK VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 125: THAILAND: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 126: THAILAND: PORCINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 127: THAILAND: POULTRY VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 128: THAILAND: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 129: INDIA: VETERINARY VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 130: INDIA: LIVESTOCK VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 131: INDIA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 132: INDIA: PORCINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 133: INDIA: POULTRY VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 134: INDIA: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 135: ROAPAC: VETERINARY VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 136: ROAPAC: LIVESTOCK VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 137: ROAPAC: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 138: ROAPAC: PORCINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 139: ROAPAC: POULTRY VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 140: ROAPAC: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 141: ROW: VETERINARY VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 142: ROW: LIVESTOCK VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 143: ROW: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 144: ROW: PORCINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 145: ROW: POULTRY VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 146: ROW: BOVINE VACCINES MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 147: ROW: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 148: RANK OF COMPANIES IN THE VETERINARY VACCINES MARKET, 2017

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN: VETERINARY VACCINES MARKET
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: VETERINARY VACCINES MARKET, BY TYPE, 2017 VS. 2022
  • FIGURE 7: VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017 VS. 2022
  • FIGURE 8: PORCINE VACCINES MARKET, BY DISEASE, 2017 VS. 2022
  • FIGURE 9: VETERINARY VACCINES MARKET, BY REGION
  • FIGURE 10: GROWTH IN LIVESTOCK POPULATION AND REPEATED BREAKOUTS OF LIVESTOCK DISEASES ARE DRIVING THE VETERINARY VACCINES MARKET
  • FIGURE 11: LIVE ATTENUATED VACCINES SEGMENT IS ESTIMATED TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2017
  • FIGURE 12: INFECTIOUS BRONCHITIS SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2017 AND 2022
  • FIGURE 13: APAC IS EXPECTED TO HAVE THE FASTEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 14: VETERINARY VACCINES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15: PORCINE VACCINES SEGMENT TO DOMINATE THE VETERINARY VACCINES MARKET IN 2017
  • FIGURE 16: LIVE ATTENUATED VACCINES SEGMENT TO DOMINATE THE VETERINARY VACCINES MARKET IN 2022
  • FIGURE 17: GEOGRAPHIC SNAPSHOT: ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
  • FIGURE 18: EUROPE: VETERINARY VACCINES MARKET SNAPSHOT
  • FIGURE 19: ASIA PACIFIC: VETERINARY VACCINES MARKET SNAPSHOT
  • FIGURE 20: ZOETIS: COMPANY SNAPSHOT (2016)
  • FIGURE 21: MERCK & CO. INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 22: BOEHRINGER INGELHEIM: COMPANY SNAPSHOT (2016)
  • FIGURE 23: ELANCO: COMPANY SNAPSHOT (2016)
  • FIGURE 24: CEVA: COMPANY SNAPSHOT (2016)
  • FIGURE 25: VIRBAC: COMPANY SNAPSHOT (2016)
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
BCC Research